Stand Up to Cancer (SU2C) is a charitable program of the Entertainment Industry Foundation (EIF). SU2C aims to raise significant funds for translational cancer research through online and televised efforts. Central to the program is a telethon that was first televised by four major broadcast networks (ABC, NBC, CBS, Fox) in over 170 countries on September 5, 2008. SU2C raised over $100 million after that evening's broadcast. [1] Funds collected by Stand Up to Cancer are then distributed by the American Association for Cancer Research. [2]
Stand Up to Cancer was conceived of in autumn 2007, by a group of women who had been affected by cancer and believe that by merging the recourse of the media and entertainment industries into a single operation they would be able to fight against this disease in a more profound way. [3]
Stand Up to Cancer was formally launched on May 27, 2008. Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. [4] All current members of the CFA were co-producers of the 2012 televised special. The late co-founder Laura Ziskin executive produced both the September 5, 2008 and September 10, 2010 broadcasts. Sung Poblete, Ph.D., R.N., has served as SU2C’s president and CEO since 2011. In the United Kingdom, Channel 4, along with Cancer Research UK, launched its own version of Stand Up to Cancer in October 2012, which has continued every year since. [5]
Stand Up to Cancer aims to raise awareness and bring about an understanding that everyone is connected to cancer. The statistic used most often by SU2C is from the American Cancer Society: one out of every two men and one out of every three women will be diagnosed with cancer in their lifetime, [6] meaning everyone is affected in some way, or will be.
The campaign has featured televised moments during World Series baseball games where fans literally "stand up to cancer" by rising and holding signs inscribed with the names of friends and loved ones who have struggled with the disease. [7]
SU2C has donated hundreds of millions of dollars since the first "Dream Team" was organized in 2009. The "Dream Teams" funded by SU2C brings researchers together from institutions and universities across the world and have been among the most productive collaborations in getting new drugs to market and many teams are funded jointly with other cancer research organizations. The research is required to be translational and include laboratory and clinical members and cannot involve more than one principal investigator from each institution. [8] [9] Many of these dream teams are co-sponsored by other cancer-related foundations.
Research led by these teams has contributed to the development of two FDA-approved treatments; palbociclib (Breast Cancer Dream Team), and abraxane plus gemcitabine (Pancreatic Cancer Dream Team). [10]
Six telethons have been broadcast in the United States and are made available to more than 190 countries. To date, more than $603 million [11] has been pledged to support SU2C’s innovative cancer research programs.
The first Stand Up to Cancer event was held on September 5, 2008, raising over $100 million. [1] The second was held on 10 September 2010. [12] The third was held on 7 September 2012, and the fourth was held on 5 September 2014, presented by Gwyneth Paltrow and Katie Couric from Los Angeles. The fifth was held on 9 September 2016. [13] The averaged combined ratings for the 2014 telethon were 1.8 from 2.1 in 2012. [14] The sixth was broadcast on 7 September 2018, raising more than $123 million. This event was aired on more than 70 broadcast and cable networks and streaming and social platforms, including: CBS, HBO and NBC. [15]
In Canada, the 2014 telethon aired September 5, 2014 in simultaneous substitution (in many areas) with the American telethon, simultaneously on English language networks CBC Television, City, CTV and Global, as well as CHCH-DT in Hamilton, Ontario, CHEK-DT in Victoria, British Columbia, CJON-DT in St. John's, Newfoundland and Labrador, and specialty channels TLN, Fight Network, Gusto TV, AMI-TV and the Hollywood Suite channels. The Canadian broadcast of the telethon benefits EIF Canada, the Canadian arm of the Entertainment Industry Foundation, with all donations benefiting cancer research in Canada. [16]
It was not held in the fall of 2020 due to the COVID-19 pandemic, but postponed to August 21, 2021.
On 19 October 2012, Channel 4 in the United Kingdom aired their first telethon for Stand Up to Cancer hosted by Davina McCall and Alan Carr along with Dr. Christian Jessen. A second telethon was broadcast on 17 October 2014, again hosted by McCall and Carr along with Dr. Jessen. Subsequent UK telethons, again on Channel 4, followed in 2016 and 2018.
Stand Up to Cancer's fundraising activities in the UK include the London 3 Peaks Challenge, which involves participants running up the stairs of Heron Tower, 30 St Mary Axe and 200 Aldersgate before abseiling down the outside of 200 Aldersgate. [17]
Despite the Original American version cancelling their telethon and ITV giving up on their Text Santa shows, Channel 4 have still scheduled a telethon over the last two years, in addition to a number of other charity celebrity specials on the network. The most recent one was held on 15 October 2021, [18] and was hosted by Alan Carr, Adam Hills, Maya Jama and Davina McCall. In addition to this, Channel 4 will be bringing back a version of the British Comedy Awards for Stand Up to Cancer, with the renamed National Comedy Awards due to be held in London on 15 December 2021. [19]
A telethon is a televised fundraising event that lasts many hours or days, the purpose of which is to raise money for a charitable, political or other cause.
Muscular Dystrophy Association (MDA) is an American nonprofit organization dedicated to supporting people living with muscular dystrophy, ALS, and related neuromuscular diseases. Founded in 1950 by Paul Cohen, who lived with muscular dystrophy, MDA accelerates research, advances care, and works to empower families to live longer and more independent lives but is perhaps known for its working relationship with comedian, entertainer and actor Jerry Lewis, its national chairman of 55 years and host of his annual telethon held live each Labor Day weekend. The organization's headquarters is in Chicago, Illinois.
Hereditary nonpolyposis colorectal cancer (HNPCC) is a hereditary predisposition to colon cancer.
Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by surgeon Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research. The center is usually called Roswell Park in short. The center, which conducts clinical research on cancer as well as the development new drugs, provides advanced treatment for all forms of adult and pediatric cancer, and serves as a member of the National Comprehensive Cancer Network. Roswell Park Comprehensive Cancer Center is as of 2019, the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center".
Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, hepatocellular carcinoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye (intravitreal).
Adjuvant therapy, also known as adjunct therapy, adjuvant care, or augmentation therapy, is a therapy that is given in addition to the primary or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments. An example of such adjuvant therapy is the additional treatment usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to the presence of undetected disease. If known disease is left behind following surgery, then further treatment is not technically adjuvant.
KRAS is a gene that provides instructions for making a protein called K-Ras, a part of the RAS/MAPK pathway. The protein relays signals from outside the cell to the cell's nucleus. These signals instruct the cell to grow and divide (proliferate) or to mature and take on specialized functions (differentiate). It is called KRAS because it was first identified as a viral oncogene in the KirstenRAt Sarcoma virus. The oncogene identified was derived from a cellular genome, so KRAS, when found in a cellular genome, is called a proto-oncogene.
The Channel Seven Perth Telethon, regionally known simply as Telethon, is an annual telethon established in 1968 by philanthropist Sir James Cruthers and Brian Treasure, and produced by TVW, a Seven Network-owned television station in Perth, Western Australia. It raises money for over 100 beneficiaries each year including the Perth Children's Hospital, the Telethon Clinical Research Centre and the Telethon Kids Institute. Channel Seven's Perth Telethon is the highest donating telethon per capita in the world, and since the first Telethon in 1968 has raised over A$650 million in total.
Tumor-associated glycoprotein 72 (TAG-72) is a glycoprotein found on the surface of many cancer cells, including ovary, breast, colon, lung, and pancreatic cancers. It is a mucin-like molecule with a molar mass of over 1000 kDa.
The Entertainment Industry Foundation (EIF), based in Los Angeles, United States, is a 501(c)(3) non-profit charitable organization of the entertainment industry. EIF funds more than 300 charitable organizations annually, both in the Los Angeles area and throughout the entire United States. To date, EIF has pledged more than $1 billion for its philanthropic initiatives.
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
Pelareorep is a proprietary isolate of the unmodified human reovirus being developed as a systemically administered immuno-oncological viral agent for the treatment of solid tumors and hematological malignancies. Pelareorep is an oncolytic virus, which means that it preferentially lyses cancer cells. Pelareorep also promotes an inflamed tumor phenotype through innate and adaptive immune responses. Preliminary clinical trials indicate that it may have anti-cancer effects across a variety of cancer types when administered alone and in combination with other cancer therapies.
Ovarian Cancer Research Alliance (OCRA) is a not-for-profit organization focused on ovarian cancer research, advocacy and patient support. The organization was formed in January 2016 when the former not-for-profit organization Ovarian Cancer Research Fund, which focused primarily on ovarian cancer research, combined with Ovarian Cancer National Alliance, which focused primarily on ovarian cancer advocacy and support programs, to form one organization.
Stand Up to Cancer (SU2C) is the UK version of Stand Up to Cancer, a US charitable television telethon, broadcast between 2012 and 2018 on the Channel 4 network in the United Kingdom, and again from 2020. The most recent edition of the telethon was on 15 October 2021, a programme which was hosted by Davina McCall, Alan Carr, Maya Jama and Adam Hills. By February 2015, the 2014 broadcast had raised £15,585,444 in pledges, in aid of cancer research.
Carlos L. Arteaga, M.D., was appointed Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center in Dallas in September 2017. Previously, he was the Associate Director for Clinical Research, director of the Center for Cancer Targeted Therapies, and professor of Cancer Biology and Medicine at Vanderbilt-Ingram Cancer Center. In 2014–2015, he was the president of the American Association for Cancer Research.
Stephen Bruce Baylin is the deputy director and associate director for research at the Sidney Kimmel Comprehensive Cancer Center and Virginia and D.K. Ludwig Professor for Cancer Research and medicine and chief of cancer biology of the Johns Hopkins University School of Medicine. His research focus is epigenetics in the development of cancer, and he was one of the first researchers in this field in the 1980s.
Daniel D. Von Hoff is the physician in chief and director of translational research at Translational Genomics Research Institute (TGen), and current Virginia G. Piper Distinguished Chair for Innovative Cancer Research at HonorHealth Clinical Research Institute. He is also a professor of medicine at the Mayo Clinic and medical director of research as well as chief scientific officer at US Oncology. He is most notable for his work in targeted therapies for the treatment of cancer. He led the development of gemcitabine, and has several drugs in development.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
Luis Alberto Diaz, Jr. is the Head of the Division of Solid Tumor Oncology in Memorial Sloan Kettering’s Department of Medicine.
Edith Peterson Mitchell was a retired Brigadier general of the United States Air Force and an oncologist. She was clinical professor of medicine and medical oncology at Thomas Jefferson University. In 2015, she became the president of the National Medical Association.